ICS

ICS GlobalASX:ICS Stock Report

Market Cap

AU$23.2m

7D

0%

1Y

18.4%

Updated

15 Sep, 2021

Data

Company Financials
ICS fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

ICS Overview

ICS Global Limited, an investment holding company, provides medical billing services primarily in the United Kingdom.

Price History & Performance

Summary of all time highs, changes and price drops for ICS Global
Historical stock prices
Current Share PriceAU$2.19
52 Week HighAU$1.62
52 Week LowAU$2.35
Beta1.27
1 Month Change0%
3 Month Change0%
1 Year Change18.38%
3 Year Change113.66%
5 Year Change41.29%
Change since IPO-95.88%

Recent News & Updates

Feb 09
Should You Buy ICS Global Limited (ASX:ICS) For Its Dividend?

Should You Buy ICS Global Limited (ASX:ICS) For Its Dividend?

Today we'll take a closer look at ICS Global Limited ( ASX:ICS ) from a dividend investor's perspective. Owning a...

Jan 05
Is ICS Global Limited's (ASX:ICS) Latest Stock Performance A Reflection Of Its Financial Health?

Is ICS Global Limited's (ASX:ICS) Latest Stock Performance A Reflection Of Its Financial Health?

ICS Global (ASX:ICS) has had a great run on the share market with its stock up by a significant 23% over the last three...

Shareholder Returns

ICSAU HealthcareAU Market
7D0%-0.8%-2.3%
1Y18.4%19.1%25.4%

Return vs Industry: ICS underperformed the Australian Healthcare industry which returned 20.3% over the past year.

Return vs Market: ICS underperformed the Australian Market which returned 25.6% over the past year.

Price Volatility

Is ICS's price volatile compared to industry and market?
ICS volatility
ICS Beta1.27
Industry Beta0.57
Market Beta1

Stable Share Price: Insufficient data to determine ICS's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine ICS's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996n/an/ahttps://icsglobal.com.au

ICS Global Limited, an investment holding company, provides medical billing services primarily in the United Kingdom. The company offers medical billing and collection services to medical consultants and specialists. ICS Global Limited was incorporated in 1996 and is based in Sydney, Australia.

ICS Global Fundamentals Summary

How do ICS Global's earnings and revenue compare to its market cap?
ICS fundamental statistics
Market CapAU$23.22m
Earnings (TTM)-AU$1.43m
Revenue (TTM)n/a

0x

P/S Ratio

-16.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ICS income statement (TTM)
RevenueAU$0
Cost of RevenueAU$42.87k
Gross Profit-AU$42.87k
ExpensesAU$1.39m
Earnings-AU$1.43m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.14
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did ICS perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

-30%

Payout Ratio

Valuation

Is ICS Global undervalued compared to its fair value and its price relative to the market?

1.02x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: ICS (A$2.19) is trading above our estimate of fair value (A$0.96)

Significantly Below Fair Value: ICS is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: ICS is unprofitable, so we can't compare its PE Ratio to the Australian Healthcare industry average.

PE vs Market: ICS is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ICS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ICS is good value based on its PB Ratio (1x) compared to the AU Healthcare industry average (1.8x).


Future Growth

How is ICS Global forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

0.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ICS Global has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has ICS Global performed over the past 5 years?

-29.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ICS is currently unprofitable.

Growing Profit Margin: ICS is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: ICS is unprofitable, and losses have increased over the past 5 years at a rate of 29.4% per year.

Accelerating Growth: Unable to compare ICS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ICS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (82.1%).


Return on Equity

High ROE: ICS has a negative Return on Equity (-6.27%), as it is currently unprofitable.


Financial Health

How is ICS Global's financial position?


Financial Position Analysis

Short Term Liabilities: ICS's short term assets (A$23.0M) exceed its short term liabilities (A$154.1K).

Long Term Liabilities: ICS has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: ICS is debt free.

Reducing Debt: ICS had no debt 5 years ago.

Debt Coverage: ICS has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: ICS has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is ICS Global current dividend yield, its reliability and sustainability?

1.83%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: ICS's dividend (1.83%) isn’t notable compared to the bottom 25% of dividend payers in the Australian market (2.19%).

High Dividend: ICS's dividend (1.83%) is low compared to the top 25% of dividend payers in the Australian market (5.15%).


Stability and Growth of Payments

Stable Dividend: ICS has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: ICS's dividend payments have increased, but the company has only paid a dividend for 9 years.


Current Payout to Shareholders

Dividend Coverage: ICS is paying a dividend but the company is unprofitable.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

11.2yrs

Average board tenure


CEO

ICS Global has no CEO, or we have no data on them.


Board Members

Experienced Board: ICS's board of directors are seasoned and experienced ( 11.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: ICS insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

ICS Global Limited's employee growth, exchange listings and data sources


Key Information

  • Name: ICS Global Limited
  • Ticker: ICS
  • Exchange: ASX
  • Founded: 1996
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: AU$23.223m
  • Shares outstanding: 10.60m
  • Website: https://icsglobal.com.au

Location

  • ICS Global Limited
  • 20 Bond Street
  • Suite 3.03
  • Sydney
  • New South Wales
  • 2000
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/15 21:51
End of Day Share Price2021/06/18 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.